Bernie Sanders rejects donation from CEO bro who raised AIDS drug price
- 9 years ago
Add Bernie Sanders' name to the long list of people who hate that CEO who massively inflated the cost of an AIDS drug.
The Vermont senator has rejected a donation from the former hedge fund manager who raised the price of an AIDS drug from $13.50 to $750 per pill, the campaign confirmed Thursday.
Martin Shkreli, the Turing Pharmaceuticals CEO who received a generous helping of Internet vitriol last month after his company bought the rights to the life-saving drug Daraprim - and then promptly raised its price by more than 5,000% - requested a meeting with Sanders and donated $2,700 to the socialist-leaning democrat's campaign.
But Sanders, an outspoken critic of prescription price gouging, said through a campaign spokesman Thursday that Shkreli's contribution would be donated to Whitman-Walker Health, a Washington, D.C. center specializing in the treatment of HIV/AIDS, on Friday.
"He is the poster boy for pharmaceutical company greed," Sanders spokesman Michael Briggs told Mashable.
The Vermont senator has rejected a donation from the former hedge fund manager who raised the price of an AIDS drug from $13.50 to $750 per pill, the campaign confirmed Thursday.
Martin Shkreli, the Turing Pharmaceuticals CEO who received a generous helping of Internet vitriol last month after his company bought the rights to the life-saving drug Daraprim - and then promptly raised its price by more than 5,000% - requested a meeting with Sanders and donated $2,700 to the socialist-leaning democrat's campaign.
But Sanders, an outspoken critic of prescription price gouging, said through a campaign spokesman Thursday that Shkreli's contribution would be donated to Whitman-Walker Health, a Washington, D.C. center specializing in the treatment of HIV/AIDS, on Friday.
"He is the poster boy for pharmaceutical company greed," Sanders spokesman Michael Briggs told Mashable.